Clinical Trials Browser

Sarcoma × Immunohistochemistry × Sarcoma × Clear all

NCT00822848 2018-09-07

Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma

Phase 1 Completed

18 enrolled

Sarcoma

NCT00004261 2018-02-22

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

Phase 1 Terminated

BreastGenitourinaryGynecologicHead & NeckSarcoma

Breast Carcinoma In Situ, Breast Neoplasms, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Inflammatory Breast Neoplasms

NCT01365949 2016-07-11

Biomarker in Tissue Samples From Patients With Ewing Sarcoma

Completed

40 enrolled

Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT01365962 2016-05-19

Clinical Trials

Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

Biomarker in Tissue Samples From Patients With Ewing Sarcoma

Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma

Protein Expression in Samples From Young Patients With Rhabdomyosarcoma

Studying Tumor Tissue Samples From Patients With Soft Tissue Sarcoma